Protection of erythropoietin on experimental spinal cord injury by reducing the expression of thrombospondin-1 and transforming growth factor-β

被引:18
作者
Fang Xiang-qian [2 ]
Fang Mei
Fan Shun-wu [2 ]
Gu Chuan-long [1 ]
机构
[1] Zhejiang Univ, Dept Cell Biol & Anat, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China
[2] Zhejiang Univ, Dept Orthopaed, Sch Med, Sir Run Run Shaw Hosp, Hangzhou 310016, Zhejiang, Peoples R China
关键词
thrombospondin-1; transforming growth factor-beta; spinal cord injury; erythropoietin; TGF-BETA; COLLAGEN; MODEL; RAT;
D O I
10.3760/cma.j.issn.0366-6999.2009.14.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Erythropoietin (EPO) functions as a tissue-protective cytokine in addition to its crucial hormonal role in red cell production and neuron protection. This study aimed to determine the neuron protective effect of erythropoietin on experimental rats enduring spinal cord injury (SCI) by assessing thrombospondin-1 (TSP-1) level and transforming growth factor-beta (TGF-beta) in the development of a rat model of SCI. Methods Sixty Sprague-Dawley rats were randomly assigned to three groups: sham operation control group, SCI group and EPO treatment group. By using a weight-drop contusion SCI model, the rats in the SCI group and EPO treatment group were sacrificed at 24 hours and 7 days subsequently. The Basso, Beattie, and Bresnahan (BBB) scores were examined for locomotor function. Pathological changes were observed after HE staining. The expressions of thrombospondin-2 (TSP-1) and TGF-beta were determined by immunohistochemical staining and Western blotting. Results Slighter locomotor dysfunction was discovered and it was recovered abruptly as higher BIBB scores were found in the EPO treatment group than in the SCI group (P<0.01). Pathologically, progressive disruption of the dorsal white matter and regeneration of a few neurons were also observed in SCI rats. TSP-1 and TGF-beta expression increased at 24 hours and 7 days after SCI in the injured segment, and it was higher in the SCI group than in the EPO treatment group. Spinal cord samples from the animals demonstrated a TSP-1 optical density of 112.2 +/- 6.8 and TSP-1 positive cells of 5.7 +/- 1.3 respectively. After injury, the TSP-1 optical density and cell number increased to 287.2 +/- 14.3/mm(2) and 23.2 +/- 2.6/mm(2) at 24 hours and to 232.1 +/- 13.2/mm(2) and 15.2 +/- 2.3/mm(2) at 7 days respectively. When EPO treated rats compared with the SCI rats, the TSP-1 optical density and cell number decreased to 213.1 +/- 11.6/mm(2) and 11.9 +/- 1.61mm(2) at 24 hours and to 189.9 +/- 10.5/mm(2) and 9.3 +/- 1.5/mm(2) at 7 days, respectively (P<0.01). In the SCI rats, the TGF-beta optical density and positive neuron number were 291.4 +/- 15.2/mm(2) and 28.8 +/- 4.9/mm(2) at 24 hours and 259.1 +/- 12.3/mm(2) and 23.9 +/- 4.1/mm(2) at 7 days respectively. They decreased in the EPO treated rats to 222.8 +/- 11.9/mm(2) and 13.7 +/- 2.1/mm(2) at 24 hours and to 196.5 +/- 9.7/mm(2) and 8.7 +/- 2.2/mm(2) at 7 days (P<0.01). Conclusions Increased expression of TSP-1 and TGF-beta can be found in the injured segment of the spinal cord at 24 hours and 7 days after injury. EPO treatment can effectively prevent pathological alterations from severe spinal cord injury by reduced expression of TSP-1 and TGF-beta. Chin Med J 2009;122(14):1631-1635
引用
收藏
页码:1631 / 1635
页数:5
相关论文
共 23 条
  • [1] TGF-beta in neural stem cells and in tumors of the central nervous system
    Aigner, Ludwig
    Bogdahn, Ulrich
    [J]. CELL AND TISSUE RESEARCH, 2008, 331 (01) : 225 - 241
  • [2] The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury
    Bornstein, P
    Agah, A
    Kyriakides, TR
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (06) : 1115 - 1125
  • [3] Thrombospondin-1 is an endogenous activator of TGF-β in experimental diabetic nephropathy in vivo
    Daniel, Christoph
    Schaub, Kathrin
    Amann, Kerstin
    Lawler, Jack
    Hugo, Christian
    [J]. DIABETES, 2007, 56 (12) : 2982 - 2989
  • [4] Deng YB, 2005, CHINESE MED J-PEKING, V118, P1533
  • [5] TGF-β activation by traction?
    Keski-Oja, J
    Koli, K
    von Melchner, H
    [J]. TRENDS IN CELL BIOLOGY, 2004, 14 (12) : 657 - 659
  • [6] Transforming growth factor-β and myostatin signaling in skeletal muscle
    Kollias, Helen D.
    McDermott, John C.
    [J]. JOURNAL OF APPLIED PHYSIOLOGY, 2008, 104 (03) : 579 - 587
  • [7] Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007
  • [8] Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth
    Lawler, J
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2002, 6 (01) : 1 - 12
  • [9] Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion
    Lin, TN
    Kim, GM
    Chen, JJ
    Cheung, WM
    He, YY
    Hsu, CY
    [J]. STROKE, 2003, 34 (01) : 177 - 186
  • [10] Erythropoietin as a neuroprotective agent in traumatic brain injury Review
    Mammis, Antonios
    Mclntosh, Tracy K.
    Maniker, Allen H.
    [J]. SURGICAL NEUROLOGY, 2009, 71 (05): : 527 - 531